Veradigm | MDRX - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Alcidion AUD 134.3M 53.72M 2025-06
Ambu A/S DKK 3.14B 21.8B 2025-12
Amplifon EUR 2.35B 786.16M 2026-03
Cardinal Health USD 48.83B 11.54B 2025-12
Centene USD 20.23B 2.7B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cigna USD 73.52B 3.42B 2025-12
Coloplast 124.69B 0 2026-02
CVS Health USD 100.74B 5.12B 2025-12
Diasorin EUR 4.23B 858.25M 2025-09
Elevance Health USD 77.91B 5.15B 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Gulf Medical Proj AED 1.52B 160.75M 2026-03
Humana USD 30.81B 485M 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Maximus USD 4.7B 307M 2025-12
McKesson USD 101.25B 5.15B 2025-12
Med Life RON 4.16B 601.5M 2025-09
Molina Healthcare USD 8.92B 1.45B 2025-12
Omnicell USD 2.03B 634M 2025-12
Oriola-kd EUR 213.12M 18.9M 2025-09
Owens Minor USD 371M 326M 2025-09
Quest Diagnostics USD 19.3B 2.01B 2025-12
Rede D'or Sao Luiz BRL 96.33B 18.17B 2025-09
Siemens Healthineers EUR 50.67B 1.24B 2025-12
Supermax Corporation Bhd MYR 1.47B 340.88M 2025-09
UnitedHealth USD 299.03B 14.21B 2025-12
Veeva Systems USD 30.4B 3.12B 2026-03
Veradigm USD 1.69B 34M 2022-09